Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions
SEC Form 4 Filing
Kevin Feeley, CFO of GeneDx Holdings Corp., reports the vesting and sale of Class A Common Stock to cover tax obligations.
Summary
- On July 29, 2024, Kevin Feeley, the Chief Financial Officer of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock.
- 753 shares were acquired through the vesting of Restricted Stock Units (RSUs).
- 274 shares were sold at a price of $33.54 to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Feeley directly owns 37,888 shares of Class A Common Stock and 5,273 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document reflects standard insider trading activity related to compensation and tax obligations, with no indication of unusual or concerning behavior.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is typical for executives to sell shares to cover tax obligations when RSUs vest.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders, as they are related to routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/29/2023 | 25% of the underlying shares of Restricted Stock Units vested. |
| 04/29/2024 | 25% of the underlying shares of Restricted Stock Units vested. |
| 07/29/2024 | Date of the reported transactions: RSU vesting and stock sale for tax obligations. |
| 07/31/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.